Lilly(US:LLY) Zacks Investment Researchยท2025-10-29 14:39Company Performance & Outlook - Eli Lilly's earnings are expected to increase by 75% this year and another 35% next year [4] - Howmet Aerospace's earnings are projected to grow by 335% this year and 184% next year [7] - MasTec's earnings are expected to rise by 60% this year and 231% next year [12] - Western Digital's earnings are projected to increase by 353% this year and another 217% next year [13] - Exxon Mobil's earnings are expected to decline by 182% due to weaker oil prices and weak chemicals [16] Valuation & Market Dynamics - Eli Lilly's PE ratio has decreased to 36 times, making it more attractive [5] - Howmet Aerospace has a PE ratio of 55, which is considered stretched [8] - MasTec is trading at 336 times earnings [12] - Western Digital has a PE ratio of 19, considered fairly cheap with its earnings growth [14] - Exxon Mobil is trading at 17 times earnings [18] Key Factors & Industry Trends - The pharmaceutical industry, particularly Eli Lilly, faces uncertainties regarding potential tariffs and manufacturing relocation to the US [3] - The success of Eli Lilly's weight loss drug pill and its pricing strategy are key factors to watch [3][4] - MasTec benefits from government spending and construction activities, including new manufacturing facilities [11] - Western Digital's data storage business is experiencing a resurgence [13] - Exxon Mobil's performance is heavily dependent on crude oil prices and the chemical sector's performance [17]